WO2003002135A3 - Herbal composition - Google Patents

Herbal composition Download PDF

Info

Publication number
WO2003002135A3
WO2003002135A3 PCT/ZA2001/000200 ZA0100200W WO03002135A3 WO 2003002135 A3 WO2003002135 A3 WO 2003002135A3 ZA 0100200 W ZA0100200 W ZA 0100200W WO 03002135 A3 WO03002135 A3 WO 03002135A3
Authority
WO
WIPO (PCT)
Prior art keywords
herbal composition
soluble
booster
tablets
conveniently
Prior art date
Application number
PCT/ZA2001/000200
Other languages
French (fr)
Other versions
WO2003002135A2 (en
Inventor
Andries Philippus Pretorius
Ingrid Pretorius
Original Assignee
Andries Philippus Pretorius
Ingrid Pretorius
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Andries Philippus Pretorius, Ingrid Pretorius filed Critical Andries Philippus Pretorius
Priority to AU2001297937A priority Critical patent/AU2001297937A1/en
Publication of WO2003002135A2 publication Critical patent/WO2003002135A2/en
Publication of WO2003002135A3 publication Critical patent/WO2003002135A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/39Convolvulaceae (Morning-glory family), e.g. bindweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants

Abstract

This invention relates to a herbal composition for use as a source of energy, an immune system stimulant and or booster, and as a libido enhancer. The herbal composition may conveniently be presented in unit dosage form and is prepared by mixing the active substances, and one or more accessory substances if desired, together to form a dry, soluble powdered blend. The herbal composition of the invention may be administered orally in the form of powder-filled capsules, tablets, or soluble powders mixed with various liquid mediums.
PCT/ZA2001/000200 2000-02-21 2001-12-12 Herbal composition WO2003002135A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2001297937A AU2001297937A1 (en) 2000-02-21 2001-12-12 Herbal composition

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ZA200004273 2000-02-21
ZA2000/4273 2001-02-21

Publications (2)

Publication Number Publication Date
WO2003002135A2 WO2003002135A2 (en) 2003-01-09
WO2003002135A3 true WO2003002135A3 (en) 2003-11-06

Family

ID=25588871

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/ZA2001/000200 WO2003002135A2 (en) 2000-02-21 2001-12-12 Herbal composition

Country Status (2)

Country Link
AU (1) AU2001297937A1 (en)
WO (1) WO2003002135A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011161529A2 (en) * 2010-06-24 2011-12-29 Edge-To-Edge Global Investments Limited Nutritional supplement

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0286847A2 (en) * 1987-04-15 1988-10-19 EFFEM GmbH Use of antigenic products for prophylaxis or therapy of disorders or diseases in the human and animal digestive systems
US5441943A (en) * 1982-05-07 1995-08-15 Carrington Laboratories, Inc. Uses of aloe products
US5609874A (en) * 1992-09-07 1997-03-11 Virostat (Na) Nvq Method of treating viral infections

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5441943A (en) * 1982-05-07 1995-08-15 Carrington Laboratories, Inc. Uses of aloe products
EP0286847A2 (en) * 1987-04-15 1988-10-19 EFFEM GmbH Use of antigenic products for prophylaxis or therapy of disorders or diseases in the human and animal digestive systems
US5609874A (en) * 1992-09-07 1997-03-11 Virostat (Na) Nvq Method of treating viral infections

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
DREYER JJ; WEHMEYER AS: "On the nutritive value of Mopanie worms", SOUTH AFRICAN JOURNAL OF SCIENCE, vol. 78, no. 1, 1982, pages 33 - 35, XP009003217 *

Also Published As

Publication number Publication date
AU2001297937A1 (en) 2003-03-03
WO2003002135A2 (en) 2003-01-09

Similar Documents

Publication Publication Date Title
LT2000064A (en) Flash-melt oral dosage formulation
EP1435240A3 (en) Solid oral dosage form comprising a combination of methformin and glibenclamide
WO2002045684A3 (en) Rapidly dispersing pharmaceutical composition comprising effervescent agents
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
YU33099A (en) Pharmaceutical composition
ATE286057T1 (en) PHARMACEUTICAL PREPARATIONS CONTAINING CLAVULANIC ACID
WO2003035051A3 (en) The use of proton sequestering agents in drug formulations
WO1998058629A3 (en) Preparation of pharmaceutical compositions
SI1341524T1 (en) Pharmaceutical preparation in the form of a paste comprising an acid-labile active ingredient
CA2282082A1 (en) Microgranules containing cisplatin
DE69923336D1 (en) ORANGE BUPRENORPHINIC MEDICINAL PRODUCTS TO BE APPLIED
MY127350A (en) Flash-melt oral dose formulations
WO2002024203A3 (en) Controlled release formulations for oral administration
IL150528A0 (en) Ibuprofen containing active agent preparation
WO2005034861A3 (en) A dried biotherapeutic composition, uses, and device and methods for administration thereof
MXPA03002807A (en) Stabilization of solid drug formulations.
ATE401075T1 (en) MEDICINAL PRODUCT CONTAINING CYTISINE
WO2007107787A3 (en) Liquid and solid dosage formulations containing date fruit (phoenix dactylifera)
WO2003002135A3 (en) Herbal composition
WO2003061557A3 (en) Levothyroxine pharmaceutical compositions, methods of making and methods of administration
ES2171110A1 (en) Pharmaceutical composition based on ibuprofen and a procedure for the preparation thereof
WO1999047172A3 (en) Oral pharmaceutical compositions to be taken without liquids, which contain inclusion complexes
WO2001066102A3 (en) Oral dosage form for administration of the combination of tegafur, uracil, folinic acid, and oxaliplatin and method of using the same
AU2001289762A1 (en) Pharmaceutical extemporary compositions
HK1055260A1 (en) Stabilization of solid thyroid drug formulations

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 2002/09429

Country of ref document: ZA

Ref document number: 200209429

Country of ref document: ZA

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP